Clinical Trial Update: Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Vebreltinib with Temozolomide for glioblastoma after surgery; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)
• Vebreltinib (vebreltinib)

Snippet

Sponsor: Huashan Hospital | Conditions: Glioblastoma | Phase 2 | Status: NOT_YET_RECRUITING